Endocrine & Metabolic Pharmacology

BIOGRAPHY

ACADEMIC POSITIONS:
• Irving Professor of Medicine, Columbia University, College of Physicians & Surgeons
• Attending Physician in Medicine, Columbia University Medical Center
• Program Director, General Clinical Research Center, Columbia University, College of Physicians & Surgeons
• Director, Irving Center for Clinical Research, Columbia University, College of Physicians & Surgeons
• Head, Division of Preventive Medicine and Nutrition, Columbia University, College of Physicians & Surgeons

HONORS AND AWARDS:
• Alpha Omega Alpha
• 1981-1986 Public Health Service Research Career Development Award
• 1981-1986 Irma T Hirschl Career Scientist Award
• 1984 Irvine H Page Award: American Heart Association – Honorable Mention
• 1986 American Society for Clinical Investigation
• 1992 Mary Rose Swartz Invited Lectureship of the New York Dietetic Association
• 1996 American Association of Physicians
• 1996 David Rubenstein Lecture of the Canadian Lipid Club
• 1997 Albert Hogan Memorial Lecture, University of Missouri
• American Heart Association Special Recognition Award

SOCIETY MEMBERSHIPS:
• American Association of Physicians
• American Society for Clinical Investigation
• American Federation of Clinical Research
• American Heart Association: Arteriosclerosis, Thrombosis, and Vascular Biology Council
• American Diabetes Association
• American Association for the Advancement of Science
• American Institute of Nutrition: American Society of Clinical Nutrition
• New York Heart Association
• New York Diabetes Association
• Clinical Society
• New York Lipid Club

RESEARCH INTERESTS:
Dr Ginsberg conducts research related to the regulation of the levels and metabolism of apolipoprotein B-containing lipoproteins, the lipoproteins carrying triglycerides and the bulk of cholesterol in blood. These include the atherogenic very low density and low density lipoproteins. Dr Ginsberg has a particular emphasis on the pathophysiology of hypertriglyceridemia and the dyslipidemia associated with insulin resistance and diabetes mellitus. Research is conducted at three levels: tissue culture using both human and rat hepatoma cells, transgenic mice, and human clinical studies.